Regulatory

Regulatory

At anytime, there are more than 300,000 clinical studies happening around the world. The process for bringing new pharmaceuticals to the market is prolonged due to regulation placed on the drugs sector to protect public safety. The stringency of this regulation is evidenced by the fact that since the Food and Drug Administration (FDA) came into being in 1938, just 1,453 drugs have been approved, despite 7.3 million drugs being reviewed during clinical development.

The FDA has long been criticized for taking too long to approve new drugs so Congress passed legislation in the 90’s aimed at speeding up the entire process. In 2004, Merck withdrew its painkiller Vioxx after studies showed the pill increased the risk of heart attacks and strokes. In this instance the FDA was highly criticized for approving medicines too easily and for delaying issuing warnings about potential drug risks. Congress attempted to amend this, so in 2016 the 21st Century Cures Act was passed. The entire process took three years for Congress to pass it and its benefits have yet to be fully seen (statnews).

In order to achieve future growth the FDA could look to India as an example. The current rate of seven to eight percent CAGR growth is expected to lead to about $80bn to $90bn in sales by 2030. According to the Indian Pharmaceutical Association, simplifying regulatory approval processes is key for the sector to experience growth.

Technology is key for moving these regularity processes forward. Organizations such as the Regulatory Affairs Professionals Society (RAPS) explores the challenges and opportunities for the regulatory affairs sector of implementing digital health solutions, data safety and data risk in the digital healthcare sector and global digital drug information sources. TORPA: The Organization for Professionals in Regulatory Affairs also highlights how future talent in the industry will need to embrace new skills, such as data analytics, to improve the regulatory process in line with technological innovation in life sciences.

Regulatory Jobs

Senior Process Chemist
Negotiable, Cleveland

Sr. Process Chemist for a Leading Pharmaceutical Organization * Greater Cleveland Area * Competi...

Apply now
Senior Process Chemist
Negotiable, New Concord

Sr. Process Chemist for a Leading Pharmaceutical Organization * Greater Cleveland Area * Competi...

Apply now
Senior Director, Regulatory CMC
Negotiable, San Diego

Company summary: An exciting biotech down in San Diego is looking to add a key member to their R...

Apply now
Manager Regulatory Affairs
US$100000 - US$100001 per annum, New Jersey

A pharmaceutical company with a diverse portfolio of products and a wealth of opportunity for gr...

Apply now
Director of Regulatory Affairs
US$170000 - US$170001 per annum, New Jersey

Our client is looking to hire for a Director of Regulatory Affairs with expertise in complex pro...

Apply now
Vice President of Regulatory Affairs
Negotiable, Munich

Vice President of Regulatory Affairs Your tasks as the Vice President of Regulatory Affairs: ...

Apply now
Associate Director Global Regulatory Affairs
Negotiable, Boston

Associate Director, Global Regulatory Affairs Greater Boston In this opportunity, you would h...

Apply now
RA - AD (Rare Disease)
Negotiable, San Diego

Title: Associate Director, Global Regulatory Affairs Company Summary After the announcement o...

Apply now
Regulatory Affairs Manager
Negotiable, San Francisco

Company summary: A pre-IPO biotech here in the Bay Area is looking to add a new member to their ...

Apply now